Drug Type Gene therapy, Hematopoietic stem cell therapy |
Synonyms lentiviral vector (LV) mediated hematopoietic stem progenitor cell (HSPCs) gene therapy |
Target- |
Action- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
RegulationOrphan Drug (European Union) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Adenosine deaminase deficiency | Discovery | Italy | 16 Nov 2020 |





